Barry D Schoub

Summary

Affiliation: National Institute for Communicable Diseases
Country: South Africa

Publications

  1. pmc Advances in childhood immunisation in South Africa: where to now? Programme managers' views and evidence from systematic reviews
    Charles Shey Wiysonge
    Vaccines for Africa Initiative, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa
    BMC Public Health 12:578. 2012
  2. doi Recommendations pertaining to the use of viral vaccines: influenza 2013
    B D Schoub
    National Department of Health, South Africa
    S Afr Med J 103:80. 2013
  3. doi Zoonotic diseases and human health: the human influenza example
    Barry D Schoub
    National Institute for Communicable Diseases, Sandringham
    Onderstepoort J Vet Res 79:489. 2012
  4. doi Introduction of inactivated polio vaccine (IPV) into the routine immunization schedule of South Africa
    Barry D Schoub
    National Institute for Communicable Diseases National Health Laboratory Service, Private Bag X4, Sandringham 2131, South Africa
    Vaccine 30:C35-7. 2012
  5. ncbi Eradication of disease - the case study of polio
    B D Schoub
    National Institute for Communicable Diseases, South Africa
    S Afr Med J 97:1177-81. 2007
  6. doi Surveillance and management of influenza on the African continent
    Barry D Schoub
    National Institute for Communicable Diseases, Private Bag X4, Sandringham 2131, South Africa
    Expert Rev Respir Med 4:167-9. 2010
  7. doi The National Advisory Group on Immunization (NAGI) of the Republic of South Africa
    Barry D Schoub
    National Institute for Communicable Diseases, Private Bag X4, Sandringham 2131, South Africa
    Vaccine 28:A31-4. 2010
  8. ncbi Phylogenetic studies of influenza B viruses isolated in southern Africa: 1998-2001
    Terry G Besselaar
    National Institute for Communicable Diseases, Private Bag X4, Sandringham 2131, South Africa
    Virus Res 103:61-6. 2004
  9. pmc Immunodeficiency-associated vaccine-derived poliovirus type 3 in infant, South Africa, 2011
    Nicksy Gumede
    National Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg, South Africa
    Emerg Infect Dis 18:992-4. 2012
  10. ncbi Antigenic and molecular analysis of influenza A (H3N2) virus strains isolated from a localised influenza outbreak in South Africa in 2003
    Terry G Besselaar
    National Institute for Communicable Diseases, Sandringham, South Africa
    J Med Virol 73:71-8. 2004

Collaborators

  • Nicksy Gumede
  • Terry G Besselaar
  • Charles Shey Wiysonge
  • Jo M McAnerney
  • Lizelle Botha
  • Anthony Hawkridge
  • Shabir A Madhi
  • Nthombenhle J Ngcobo
  • Gregory D Hussey
  • Prakash M Jeena
  • Muki S Shey

Detail Information

Publications10

  1. pmc Advances in childhood immunisation in South Africa: where to now? Programme managers' views and evidence from systematic reviews
    Charles Shey Wiysonge
    Vaccines for Africa Initiative, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa
    BMC Public Health 12:578. 2012
    ..We assessed challenges and enablers for the programme in South Africa, as we approach the 2015 deadline for the Millennium Development Goals...
  2. doi Recommendations pertaining to the use of viral vaccines: influenza 2013
    B D Schoub
    National Department of Health, South Africa
    S Afr Med J 103:80. 2013
    ..For a review of the 2012 influenza season, please refer to the website of the National Institute for Communicable Diseases of the National Health Laboratory Service (http://www.nicd.ac.za)...
  3. doi Zoonotic diseases and human health: the human influenza example
    Barry D Schoub
    National Institute for Communicable Diseases, Sandringham
    Onderstepoort J Vet Res 79:489. 2012
    ....
  4. doi Introduction of inactivated polio vaccine (IPV) into the routine immunization schedule of South Africa
    Barry D Schoub
    National Institute for Communicable Diseases National Health Laboratory Service, Private Bag X4, Sandringham 2131, South Africa
    Vaccine 30:C35-7. 2012
    ..Thirdly, to address equity concerns because of the growing use of IPV in the private sector. Fourthly, the advent of combination vaccines facilitated the incorporation of IPV into the EPI schedule...
  5. ncbi Eradication of disease - the case study of polio
    B D Schoub
    National Institute for Communicable Diseases, South Africa
    S Afr Med J 97:1177-81. 2007
    ..It is the largest international public health initiative ever undertaken, costing several billion dollars and immunising billions of children worldwide. It has also been mired in controversy almost since its outset...
  6. doi Surveillance and management of influenza on the African continent
    Barry D Schoub
    National Institute for Communicable Diseases, Private Bag X4, Sandringham 2131, South Africa
    Expert Rev Respir Med 4:167-9. 2010
    ..How important it is to have a comprehensive surveillance facility in all parts of the world has been graphically illustrated by the totally unexpected and unpredicted start of the 2009 novel influenza A (H1N1) pandemic in North America...
  7. doi The National Advisory Group on Immunization (NAGI) of the Republic of South Africa
    Barry D Schoub
    National Institute for Communicable Diseases, Private Bag X4, Sandringham 2131, South Africa
    Vaccine 28:A31-4. 2010
    ..NAGI brings together experts from a range of different fields relevant to vaccines and vaccinations and has been an important resource for guiding the Expanded Program of Immunization (EPI) in South Africa...
  8. ncbi Phylogenetic studies of influenza B viruses isolated in southern Africa: 1998-2001
    Terry G Besselaar
    National Institute for Communicable Diseases, Private Bag X4, Sandringham 2131, South Africa
    Virus Res 103:61-6. 2004
    ..These molecular epidemiological studies reveal a diverse and complex pattern of influenza B virus strains circulating in southern Africa...
  9. pmc Immunodeficiency-associated vaccine-derived poliovirus type 3 in infant, South Africa, 2011
    Nicksy Gumede
    National Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg, South Africa
    Emerg Infect Dis 18:992-4. 2012
    ..We report a case of type 3 immunodeficiency-associated vaccine-derived poliovirus in a child in South Africa who was born with X-linked immunodeficiency syndrome...
  10. ncbi Antigenic and molecular analysis of influenza A (H3N2) virus strains isolated from a localised influenza outbreak in South Africa in 2003
    Terry G Besselaar
    National Institute for Communicable Diseases, Sandringham, South Africa
    J Med Virol 73:71-8. 2004
    ..The rapid spread of these variant viruses to the southern hemisphere indicates that the H3N2 component of the influenza vaccine needs to be updated for the 2004 southern hemisphere winter...